{"ticker": {"uuid": "5fd35022-8748-4a7e-8642-5914f23e4388", "symbol": "IMU", "name": "Imugene Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Imugene Limited Reports Lapse of 5,845 Restricted Stock Units Following Unmet Conditions", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQT2EzNkhVR0FJd2pIc29zQ1B3anFXelVkLXNRU2J3am52QVZGNjFJZWo0Y3VvMFdzM1lQdmhxVWRLUFlzQzJZNjV2X2UwZ2lSOS12dkZPSGxGOXpLWk8zbjdTc2d5WEdQQnZLem9DdGZaUm42em9FN19EdmtFR2ZTa1lZc2pkUXZHTTUyQThiN3dMWWFTZXJyTHB1b2llRWNyUzFBbXFQTWZkM0N4Y2pibzhvZVVxT2c5OWhMbHI5Z3lDUmFQcEwzSQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-17T06:43:11+00:00", "published_display": "17 Jul 2026 06:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU) Shares Slide as Investors Weigh the Next Stage of Its Cancer-Immunotherapy Strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOdWdHZDRLMDNlVW1wXzZWTDRLS09SLVp4T3BqTDVob0VCTFdfZTUzelRpNzB4dGpmV0V0VWo1TFRHVXBONE9SRFFQZzJZNjhVVng4MnVQTUg3SDBYY0l4SGFGcXlXSktGNndaQU1nRllZc3pjaTFPc3hCY1NSVXFiRXRpcTZRekJTWnYtUUs2VFZoRGJ1a2RWenFSQ3F0RFJwRkJLaDVUTUszeU9Mb1F0aWEwLWtZZjltU1ZMY093TGpUUHNyWUF0aXNZMjI3blYtbmt3?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T08:16:00+00:00", "published_display": "13 Jul 2026 08:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene Limited Announces Quotation of 73.7 Million New Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPNEp6cmFMUlVsSlRYMUN0d2NUa3h4RzV0czBmTEs0R2hhaUk2QmV1T251clBfQWdhT3dITXdFdldJN2xQRTUtWFMxbTFULWozcTZXcy1hYUlicW56NVhNenZsZnpELTRGSXdUbmIzQmxhdGxJNU41QmRQQndST1pVampvQ0FRcXNEcUUyUGF3d2FJMHhWNGVhSVdzdDBJeG45NWZGZ0tR?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T07:49:08+00:00", "published_display": "13 Jul 2026 07:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene Updates Director Equity Holdings for Jakob Dupont", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxORnUwdjhYUDFTMGVaU3p1cFV5SVkyRFc1ZjFvSm85T2s5dXROWThLQ3JsdE5EWWowTm12UEtiNlRkSkpVYXhSREpIdllXOEhxSDJjaUVvSFFpRGdKV2YyUFVuWXEtMWk5azZpWGgzQm1XdUwyNEFCRng2LW1ITUUxbEREZF83MmhCQUdzbGtlQmIwOHNhWjBSYmpHdU0tck1YOE9HWTdTWVBDenVUeFRmLTJtdWFjQ1RBMTRmUGdFdHMtenJIbTZDZ0t0N29vT21oU3d0dw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-08T07:14:00+00:00", "published_display": "08 Jul 2026 07:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Imugene (ASX: IMU) Plunge More Than 22% Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOazgzRnpjaHJxeXRjRUpvNURvQlUzRXBBdmNDdHJWWWFCVW96TWl4NzdIbm1zZXFJSkJfTm5YX2oybUgya1NERmFTeVJBVUdWQUxZV1FXMnJTR0d5NjQ1YXdqQWdoZmdOWEtseG14Z2Z6Y2hnNGEyUzNjR1Jjd056SjNDSGoyNWdfVzdMNmJtMFBNdw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-07T13:25:00+00:00", "published_display": "07 Jul 2026 13:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clinical Trial Progress Sparks Fresh Interest in Imugene (ASX: IMU) Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxORm1RcW90OXFDR0hVQXVTSjlTZFFjTG0wT1Y0cTBVaGotQmFqRlEzTWdHMS1hME00LWNDZC1DR3NQRzRWWmhEOVRTeC04TnAxeVJfb2pDLTlTNUVKNnkxYTJSMEJyVDF2WkN4aWpRRk5NQ2Q2d3l3T3ZVRDJTVmFkQ2l3d1ZpNnpBLTBod2RsWjB5YVd1VzBQbUwzVFFzSjRXdXNPZlc0WXpWU1haMTFYS1JR?oc=5", "source_name": "Kalkine", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis on One ASX -Listed Pharmaceuticals, Biotechnology & Life Sciences Stock \u2013 IMU", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxObVVYclBQTjB5am00Qm84QUl2SWdoTmk3Y0FqUVJmYTBiUEZnMUtPenB4eEVHdkhEelpSVnlBcUFqdmlzS2VnWWdUMHp6d2t2QzBkZ1YtSFQ1ZGpnaXY0R0U3eFdMa3lWaXVZQ3VDT2xwWmZhbHlLeVFBMWhBMXJYdFU5NmstMW5LaVNPLVFXelVSdXFGcW9JZk1rMTRUVXFkZzFuSW9GR2ZSSXhNeWNpMTVLMFRSc1NtRURyVzYyN193UmpQOUV3Mg?oc=5", "source_name": "Kalkine", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene reports first complete trial patient response", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNMG9pRUJxMEhUa3ZrZVJxSmktdzlwUmJydVByTWVsSW9iM2xzbElGc0RBd0VFd0t5Rjl6eDFoMFZMWU56SjFHLUkzWk9NbW9EQnRWY0pLOEwxTjRsYjFDOFZUS0dfTm1ocUlnZWJtTlF1aklOemNpSDhxX2dQZG1UaG9QbDMxLWgwdTJwMk81ZUk3VWM?oc=5", "source_name": "grafa.com", "published_at": "2026-06-30T04:05:24+00:00", "published_display": "30 Jun 2026 04:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU): : Is This Biotech About To Surprise The Market?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOMGU5Y1lwaUpxVlFpd0VTbERGcEt5bUF0QWFkU1Nuam9hQUNrcWlqb29OOEtYVlJrMnRtVFRpbXd2WEtxRkFpd0lDSlB3ZUFFNDN2eVVkUjI1T1lncTFVSVlHazlrTHE5VldVRUR3d21wWE9wa2pUN28wREktajFfeHpjYzlIbDE4OVBqMmY5N0dIS253aDJOcjBDWjJTUXM?oc=5", "source_name": "Kalkine", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU): Biotech Stock Rockets as FDA Fast Track News Ignites Investor Excitement", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxObUdoV1JpeVlmYjhzS0NHQngtbkdobUIwYnNyd291ajR1aTdaMkpOTE5HMzBmV2lDRVNIRTdGUmZHZ3F2Ukg2TEloX2twYWpDS0lxcE80M3R4NU9NVG4yUUJyTFRUd3JrNER4dTNJRDFETjlwTk1abnJGN3BEZHBhVlk0QVpiUldxNTkzSUIxM0ViR2xWN0dlcW91SzdYWkk1aDJrcGxfUHcwTXdSN1hfcXI2SFJVSGlCY3RBMUpFUmwtX1hq?oc=5", "source_name": "Kalkine", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU) Shares Rally as FDA Grants Special Status to Lead Cancer Therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPeklFWDVDaXJQSEQxaVk3LWhDSEFnRFoybFRVMVFvVUFVUi1WQ2JFa0tkV2pxalBHMUE1QzhTNU1aMHVQVzhXeXJTRFpmR0ltaWl4M2RXcmx1NmZyb1N5a2J3VkRIUnlRWlhpSlAwd0hUcGdkYXp1V1pWU0ZDbHdqM29PX0xHdmo2dkFadi1KVUl0Ry04eTFpeWlPVGxlNkpNTE1FUjJ0UHpzQlNvSy1QTGlsbUFjc3JJSHc?oc=5", "source_name": "Kalkine", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU) Progresses Blood Cancer Program With New Patient Dosing Milestone", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOOFVpODZsQ1FwdnZaQlNTWkt6S2RiejZpVkFJOEgxODBsYXdvZjB6NW8zY3lobV9KZ0hDN2drR0RRSlZJeHMwc1Bra1lrUndYNkZDQ09McnNDaXdFRnM1SzQ2cEJmQXBrajRNckRUUjZ0SVBwazZ1d1V3eE1OSXhhYnl6SmlrVDNsODhnZmFIZEZVQWU2SmR6SUo2NlhBUmRBUW11RVFvMkpucmZZZDRWNzg4eDI1WEZUbU5B?oc=5", "source_name": "Kalkine", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX-listed Imugene doses first azer-cel combination patient", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOVzZ0ZVRGUmlOTmhvZTFlVkwxVW1TNVNfX29ieG9IV0dqaFNybmhaY3ZlMUpBeXNkYVg2MEdzV3JOMHpzQUpZb2VyNlRHOUNkdnNOdFVPNy0yd0ZraS1wYms4Yl9hcFJFTW9QZ0JnM0V6cjZMOFFhMGVBaU0tSk9hY0JXdTA3Q0tWOXg0cg?oc=5", "source_name": "grafa.com", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene strengthens board with biotech and pharma appointments", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPaU4wcm9PMzlsZ0FwM3FqYjBTVk1nb0E5OW9CUzhIOUtycElFQktVVDZBUDN6MnRBS09PRDVpV3NTOUNfazBTenh6RkxDODRKd3c3d3RYUkJGVWlNZi0yR2FwWG1sd3BvV0ZLRHB5N3BYV3Z6LUEtWjBtY0JDWm1pdTd5U084NjQzclpVcS0weEZPYlJiajZISFB0eUc4dWd2c1Nablp6dTlrT21BbF9VU1cyZUFzWDA3RU4tdVRncHlxT09YZFR4bWttRXlDN1JycFE?oc=5", "source_name": "Proactive financial news", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What\u2019s Fuelling Imugene\u2019s (ASX: IMU) 20% Rally on ASX Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQczNOREptLWpqXzJkQl9Bb0JlVmNzUDhZTm82TVdFYWswSXJmSm9qUzhJQ1NPMjAxT0plN25UZnhpVk83UVo5dERnejlZQ2Q0ZmF3T1ZjOGk2cHFUaU5QdHBlYjg4Nm9TRmlmVDR2Vmd3R29SbFA3ZWxsWndHR2NGV3o0azhwTnZpRmxVb0RSZzE1c1NxbGU4?oc=5", "source_name": "Kalkine", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene flags strong azer-cel response rates and ASCO milestone in March quarter update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxONk8yaFkzbUplVVZyQk9KRzh5Z01tRTlnOHhTOUdJUjRCeXktMnFxcUplNWJaby1ybEJndjRnb2tzQkY4blNpNUhJUkpNaDQtUzlzSDFiTUFFSk5vUkRSdXcxTDFDZlRaN1pHUGNVcXZkOVFtQkhER1pMSGJLdmpaMER0eEVYWUdqZFJJMkNsMl9wZXkxVU9WRWIzU3hUdi00WjE0dEpRbkM4c3ZJQkM4NkVDdkRaYXBWQXFyTW1ZZ2hacU5PNGJoeElZRkNIZ3B2VjFFUXdrOUUwSEM0SWxuTF8xZUs2b015QW9yX3VYX0MxU3M?oc=5", "source_name": "Proactive financial news", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX All Ordinaries Update: Imugene (ASX:IMU) Biotech Milestone Impact?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPaDktdV9fcmVvZ253d0dRTC14elMwZHZ2NFN0aEpHbVFJMEtidzVScUFtMFhiQl9EX0VENmZPM2hDWWdVQkJpRm5uZXVkeFVNRVU5TlZ0a3JsUGZ2YnpJZ3FBQVB2b2NUeC1yX2lJVHJMWjRESURnQnFXenJiWUZyWXpxUUV2Yk1YYTZCM1V1YlRzd1JJa2NMMjU3RTVteWFGQ2RKclFETUcwOUVDVV9SeQ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene lands ASCO oral slot in high-profile azer-cel milestone", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxORzg5LTQ1aVU0VnhPLW9vNEJSWmEwcVBZR0FJVmdxWlRzbWhGUzZVd2VIeWxhWmNwTGZjWS1KWFNzV3duZVlBeTJlNEZjdnFsdjlVSDIyNWNfOWdwdWU1OGlxZEl0WS1fVE9mN2cwZVRMb1pHcmEzQ1FvSDJCc1dkbDhGc1h0bm83T0h3bUVnY05pUkxiRlFFdXcyNTZaeTdSSkhNWXJQTmlXNVB0UFhoRUZZWm1jSzZtRV9BdU95N3VOdG9XbGprYjdpelpEM29ubkJJ?oc=5", "source_name": "Proactive financial news", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU) Announces 35M Share Placement, Shares in Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNRDdqOEZBWmpwTThBY1VmYlk2RlhWZC1nbVJqUEZnTndIMm5kQVhJck42SUJFN011d29vUjlwNERlRWR1Ukx0bmJ1RUI2TUFIVjZzNi1rYkJCV0xMV1BIWjRja0VXZ0pmZHBselplcUJtRGNLeUJndzBKQmFVZ3kyMko2NEtGdnVDNHJMZk5USVBFVHNfMzBhM2RCbUtHTU55?oc=5", "source_name": "Kalkine", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene launches $20 million capital raise to fund expansion of Azer Cel trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOVFE4clpUOWNiS0otblBnS1h0SnE1UkdnY3ZJVjR2UlFJUkgzbW00RkJhdDJiRy1PYktyRGZIUHNDZnZ3UnQtQm9iRGZ1alM1RnZlMGJiY1VGbUxORWQ3RU83WnlWQnR1YzlxakJGRU1Wa2tYYUgxbk5VVkpNYVpfaTdXYzBHQXdYQmkyUlpQaUpjMG8tUlFSR3JtUFV0dlVNUWluZEtmZnNqSTAycUZKMlEzS3k?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU) Shares Drop 17.39% Despite Azer-cel CAR-T Therapy Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNbi1LY0QwNVdDa0pTeTVzbVdhbTNybDFUYTExUjZ3MEl6bzVjX25lVXlmcEE2dEZaV284X1Z2V2Y2dk9nbVFjdEFCNnFhTFYzeW4wbzRDVDRtaS1XdHo3SHg0ZHN4NTh6amVIc3EwQVdqTnVXcUxqWlRrTG9COHlDajl0VUNNWnd3aFJta0QzdW5hLUZIQkRJemNzd24zLTdqU1JTd200bEt6REE?oc=5", "source_name": "Kalkine", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMHlBODU4V2RzcnUybkFoWHo0RlViWG5vYmQwYlNOZ1gwUXh6bDl0OHJuWFFFSnhYTkRsSDBJLTdPSHpUVnVnTFljZjZPV3ZaNnFzX3EwVHBlUUtXU1R6c0ZuZXRoZlpkOHVsRlRFNFF5X1otRjdhb1dKSDlZcmdCRDMyOU9XT3BrSXZSQjROZFFTZzdGSWFKT0w0WVRJRXJKRWVpX0NQSUhoVUlKLTdSeUhXRmZKNHV6?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2025-12-08T08:00:00+00:00", "published_display": "08 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene's CAR-T therapy hits 82% response rate", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOT01ZWVVpbEZTVHk5dnBvVW8yZW80b1RfTW80TUZzTXZLZ2RkbEtQM0tVY0trOU5QWkpmaF9Fako5VEx4X042SXI3eEhjRjBpc1pQZGdUenVGcFM5dG1XazZ2cWpHd01XWVR3M1ZEajc4SVFJMUtiVU53cVd3RGRheThUN1BnbEs5bktRd3Z4UGd3Y1kwRDMwNHVTVE1XTG9nX0F3aUczVXFHZnFOV3h3TkRGdFRGRFNncUpB?oc=5", "source_name": "Proactive financial news", "published_at": "2025-12-01T08:00:00+00:00", "published_display": "01 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Imugene Ltd (ASX:IMU)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE91UXhRS0RlZUM4ODNYWW1WVWFYYVprNU5pLTA2b1FLZEkwWDRTY0hZWjdmWDFNNGtUQ0lBNGFzX2x3cG1SOWRQUXp2ZVJlRUMt?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T13:06:08+00:00", "published_display": "30 Oct 2025 13:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s what biotech Imugene needs to do before it can become a multibagger again", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxORHcwNWExQmYxQ2cwREhHb2ptaUUzOC05WTdSTWlwbVE4Z0FlQzlMc1Vmc1FBbUhBWm5NNmFLUldXbG5LNXRnaVpIYUhBczlhQ3Z4d24yRDJPV2NUY255SWxkQzNKczNYWXEzM3A3UHpVV2ZnNXhGaVM5R3NLaGthZTVQNy1sdmctNzgxT0VFSUVGdTZnWGxiWlltV1ZlR3daSzAzR25vZFhHaUJ2b3dPN3B3?oc=5", "source_name": "Stockhead", "published_at": "2022-08-25T07:00:00+00:00", "published_display": "25 Aug 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Imugene Limited Reports Lapse of 5,845 Restricted Stock Units Following Unmet Conditions", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQT2EzNkhVR0FJd2pIc29zQ1B3anFXelVkLXNRU2J3am52QVZGNjFJZWo0Y3VvMFdzM1lQdmhxVWRLUFlzQzJZNjV2X2UwZ2lSOS12dkZPSGxGOXpLWk8zbjdTc2d5WEdQQnZLem9DdGZaUm42em9FN19EdmtFR2ZTa1lZc2pkUXZHTTUyQThiN3dMWWFTZXJyTHB1b2llRWNyUzFBbXFQTWZkM0N4Y2pibzhvZVVxT2c5OWhMbHI5Z3lDUmFQcEwzSQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-17T06:43:11+00:00", "published_display": "17 Jul 2026 06:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU) Shares Slide as Investors Weigh the Next Stage of Its Cancer-Immunotherapy Strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOdWdHZDRLMDNlVW1wXzZWTDRLS09SLVp4T3BqTDVob0VCTFdfZTUzelRpNzB4dGpmV0V0VWo1TFRHVXBONE9SRFFQZzJZNjhVVng4MnVQTUg3SDBYY0l4SGFGcXlXSktGNndaQU1nRllZc3pjaTFPc3hCY1NSVXFiRXRpcTZRekJTWnYtUUs2VFZoRGJ1a2RWenFSQ3F0RFJwRkJLaDVUTUszeU9Mb1F0aWEwLWtZZjltU1ZMY093TGpUUHNyWUF0aXNZMjI3blYtbmt3?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T08:16:00+00:00", "published_display": "13 Jul 2026 08:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene Limited Announces Quotation of 73.7 Million New Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPNEp6cmFMUlVsSlRYMUN0d2NUa3h4RzV0czBmTEs0R2hhaUk2QmV1T251clBfQWdhT3dITXdFdldJN2xQRTUtWFMxbTFULWozcTZXcy1hYUlicW56NVhNenZsZnpELTRGSXdUbmIzQmxhdGxJNU41QmRQQndST1pVampvQ0FRcXNEcUUyUGF3d2FJMHhWNGVhSVdzdDBJeG45NWZGZ0tR?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T07:49:08+00:00", "published_display": "13 Jul 2026 07:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene Updates Director Equity Holdings for Jakob Dupont", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxORnUwdjhYUDFTMGVaU3p1cFV5SVkyRFc1ZjFvSm85T2s5dXROWThLQ3JsdE5EWWowTm12UEtiNlRkSkpVYXhSREpIdllXOEhxSDJjaUVvSFFpRGdKV2YyUFVuWXEtMWk5azZpWGgzQm1XdUwyNEFCRng2LW1ITUUxbEREZF83MmhCQUdzbGtlQmIwOHNhWjBSYmpHdU0tck1YOE9HWTdTWVBDenVUeFRmLTJtdWFjQ1RBMTRmUGdFdHMtenJIbTZDZ0t0N29vT21oU3d0dw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-08T07:14:00+00:00", "published_display": "08 Jul 2026 07:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Imugene (ASX: IMU) Plunge More Than 22% Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOazgzRnpjaHJxeXRjRUpvNURvQlUzRXBBdmNDdHJWWWFCVW96TWl4NzdIbm1zZXFJSkJfTm5YX2oybUgya1NERmFTeVJBVUdWQUxZV1FXMnJTR0d5NjQ1YXdqQWdoZmdOWEtseG14Z2Z6Y2hnNGEyUzNjR1Jjd056SjNDSGoyNWdfVzdMNmJtMFBNdw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-07T13:25:00+00:00", "published_display": "07 Jul 2026 13:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clinical Trial Progress Sparks Fresh Interest in Imugene (ASX: IMU) Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxORm1RcW90OXFDR0hVQXVTSjlTZFFjTG0wT1Y0cTBVaGotQmFqRlEzTWdHMS1hME00LWNDZC1DR3NQRzRWWmhEOVRTeC04TnAxeVJfb2pDLTlTNUVKNnkxYTJSMEJyVDF2WkN4aWpRRk5NQ2Q2d3l3T3ZVRDJTVmFkQ2l3d1ZpNnpBLTBod2RsWjB5YVd1VzBQbUwzVFFzSjRXdXNPZlc0WXpWU1haMTFYS1JR?oc=5", "source_name": "Kalkine", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis on One ASX -Listed Pharmaceuticals, Biotechnology & Life Sciences Stock \u2013 IMU", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxObVVYclBQTjB5am00Qm84QUl2SWdoTmk3Y0FqUVJmYTBiUEZnMUtPenB4eEVHdkhEelpSVnlBcUFqdmlzS2VnWWdUMHp6d2t2QzBkZ1YtSFQ1ZGpnaXY0R0U3eFdMa3lWaXVZQ3VDT2xwWmZhbHlLeVFBMWhBMXJYdFU5NmstMW5LaVNPLVFXelVSdXFGcW9JZk1rMTRUVXFkZzFuSW9GR2ZSSXhNeWNpMTVLMFRSc1NtRURyVzYyN193UmpQOUV3Mg?oc=5", "source_name": "Kalkine", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene reports first complete trial patient response", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNMG9pRUJxMEhUa3ZrZVJxSmktdzlwUmJydVByTWVsSW9iM2xzbElGc0RBd0VFd0t5Rjl6eDFoMFZMWU56SjFHLUkzWk9NbW9EQnRWY0pLOEwxTjRsYjFDOFZUS0dfTm1ocUlnZWJtTlF1aklOemNpSDhxX2dQZG1UaG9QbDMxLWgwdTJwMk81ZUk3VWM?oc=5", "source_name": "grafa.com", "published_at": "2026-06-30T04:05:24+00:00", "published_display": "30 Jun 2026 04:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU): : Is This Biotech About To Surprise The Market?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOMGU5Y1lwaUpxVlFpd0VTbERGcEt5bUF0QWFkU1Nuam9hQUNrcWlqb29OOEtYVlJrMnRtVFRpbXd2WEtxRkFpd0lDSlB3ZUFFNDN2eVVkUjI1T1lncTFVSVlHazlrTHE5VldVRUR3d21wWE9wa2pUN28wREktajFfeHpjYzlIbDE4OVBqMmY5N0dIS253aDJOcjBDWjJTUXM?oc=5", "source_name": "Kalkine", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU): Biotech Stock Rockets as FDA Fast Track News Ignites Investor Excitement", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxObUdoV1JpeVlmYjhzS0NHQngtbkdobUIwYnNyd291ajR1aTdaMkpOTE5HMzBmV2lDRVNIRTdGUmZHZ3F2Ukg2TEloX2twYWpDS0lxcE80M3R4NU9NVG4yUUJyTFRUd3JrNER4dTNJRDFETjlwTk1abnJGN3BEZHBhVlk0QVpiUldxNTkzSUIxM0ViR2xWN0dlcW91SzdYWkk1aDJrcGxfUHcwTXdSN1hfcXI2SFJVSGlCY3RBMUpFUmwtX1hq?oc=5", "source_name": "Kalkine", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU) Shares Rally as FDA Grants Special Status to Lead Cancer Therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPeklFWDVDaXJQSEQxaVk3LWhDSEFnRFoybFRVMVFvVUFVUi1WQ2JFa0tkV2pxalBHMUE1QzhTNU1aMHVQVzhXeXJTRFpmR0ltaWl4M2RXcmx1NmZyb1N5a2J3VkRIUnlRWlhpSlAwd0hUcGdkYXp1V1pWU0ZDbHdqM29PX0xHdmo2dkFadi1KVUl0Ry04eTFpeWlPVGxlNkpNTE1FUjJ0UHpzQlNvSy1QTGlsbUFjc3JJSHc?oc=5", "source_name": "Kalkine", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU) Progresses Blood Cancer Program With New Patient Dosing Milestone", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOOFVpODZsQ1FwdnZaQlNTWkt6S2RiejZpVkFJOEgxODBsYXdvZjB6NW8zY3lobV9KZ0hDN2drR0RRSlZJeHMwc1Bra1lrUndYNkZDQ09McnNDaXdFRnM1SzQ2cEJmQXBrajRNckRUUjZ0SVBwazZ1d1V3eE1OSXhhYnl6SmlrVDNsODhnZmFIZEZVQWU2SmR6SUo2NlhBUmRBUW11RVFvMkpucmZZZDRWNzg4eDI1WEZUbU5B?oc=5", "source_name": "Kalkine", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX-listed Imugene doses first azer-cel combination patient", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOVzZ0ZVRGUmlOTmhvZTFlVkwxVW1TNVNfX29ieG9IV0dqaFNybmhaY3ZlMUpBeXNkYVg2MEdzV3JOMHpzQUpZb2VyNlRHOUNkdnNOdFVPNy0yd0ZraS1wYms4Yl9hcFJFTW9QZ0JnM0V6cjZMOFFhMGVBaU0tSk9hY0JXdTA3Q0tWOXg0cg?oc=5", "source_name": "grafa.com", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene strengthens board with biotech and pharma appointments", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPaU4wcm9PMzlsZ0FwM3FqYjBTVk1nb0E5OW9CUzhIOUtycElFQktVVDZBUDN6MnRBS09PRDVpV3NTOUNfazBTenh6RkxDODRKd3c3d3RYUkJGVWlNZi0yR2FwWG1sd3BvV0ZLRHB5N3BYV3Z6LUEtWjBtY0JDWm1pdTd5U084NjQzclpVcS0weEZPYlJiajZISFB0eUc4dWd2c1Nablp6dTlrT21BbF9VU1cyZUFzWDA3RU4tdVRncHlxT09YZFR4bWttRXlDN1JycFE?oc=5", "source_name": "Proactive financial news", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What\u2019s Fuelling Imugene\u2019s (ASX: IMU) 20% Rally on ASX Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQczNOREptLWpqXzJkQl9Bb0JlVmNzUDhZTm82TVdFYWswSXJmSm9qUzhJQ1NPMjAxT0plN25UZnhpVk83UVo5dERnejlZQ2Q0ZmF3T1ZjOGk2cHFUaU5QdHBlYjg4Nm9TRmlmVDR2Vmd3R29SbFA3ZWxsWndHR2NGV3o0azhwTnZpRmxVb0RSZzE1c1NxbGU4?oc=5", "source_name": "Kalkine", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene flags strong azer-cel response rates and ASCO milestone in March quarter update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxONk8yaFkzbUplVVZyQk9KRzh5Z01tRTlnOHhTOUdJUjRCeXktMnFxcUplNWJaby1ybEJndjRnb2tzQkY4blNpNUhJUkpNaDQtUzlzSDFiTUFFSk5vUkRSdXcxTDFDZlRaN1pHUGNVcXZkOVFtQkhER1pMSGJLdmpaMER0eEVYWUdqZFJJMkNsMl9wZXkxVU9WRWIzU3hUdi00WjE0dEpRbkM4c3ZJQkM4NkVDdkRaYXBWQXFyTW1ZZ2hacU5PNGJoeElZRkNIZ3B2VjFFUXdrOUUwSEM0SWxuTF8xZUs2b015QW9yX3VYX0MxU3M?oc=5", "source_name": "Proactive financial news", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX All Ordinaries Update: Imugene (ASX:IMU) Biotech Milestone Impact?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPaDktdV9fcmVvZ253d0dRTC14elMwZHZ2NFN0aEpHbVFJMEtidzVScUFtMFhiQl9EX0VENmZPM2hDWWdVQkJpRm5uZXVkeFVNRVU5TlZ0a3JsUGZ2YnpJZ3FBQVB2b2NUeC1yX2lJVHJMWjRESURnQnFXenJiWUZyWXpxUUV2Yk1YYTZCM1V1YlRzd1JJa2NMMjU3RTVteWFGQ2RKclFETUcwOUVDVV9SeQ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene lands ASCO oral slot in high-profile azer-cel milestone", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxORzg5LTQ1aVU0VnhPLW9vNEJSWmEwcVBZR0FJVmdxWlRzbWhGUzZVd2VIeWxhWmNwTGZjWS1KWFNzV3duZVlBeTJlNEZjdnFsdjlVSDIyNWNfOWdwdWU1OGlxZEl0WS1fVE9mN2cwZVRMb1pHcmEzQ1FvSDJCc1dkbDhGc1h0bm83T0h3bUVnY05pUkxiRlFFdXcyNTZaeTdSSkhNWXJQTmlXNVB0UFhoRUZZWm1jSzZtRV9BdU95N3VOdG9XbGprYjdpelpEM29ubkJJ?oc=5", "source_name": "Proactive financial news", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU) Announces 35M Share Placement, Shares in Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNRDdqOEZBWmpwTThBY1VmYlk2RlhWZC1nbVJqUEZnTndIMm5kQVhJck42SUJFN011d29vUjlwNERlRWR1Ukx0bmJ1RUI2TUFIVjZzNi1rYkJCV0xMV1BIWjRja0VXZ0pmZHBselplcUJtRGNLeUJndzBKQmFVZ3kyMko2NEtGdnVDNHJMZk5USVBFVHNfMzBhM2RCbUtHTU55?oc=5", "source_name": "Kalkine", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene launches $20 million capital raise to fund expansion of Azer Cel trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOVFE4clpUOWNiS0otblBnS1h0SnE1UkdnY3ZJVjR2UlFJUkgzbW00RkJhdDJiRy1PYktyRGZIUHNDZnZ3UnQtQm9iRGZ1alM1RnZlMGJiY1VGbUxORWQ3RU83WnlWQnR1YzlxakJGRU1Wa2tYYUgxbk5VVkpNYVpfaTdXYzBHQXdYQmkyUlpQaUpjMG8tUlFSR3JtUFV0dlVNUWluZEtmZnNqSTAycUZKMlEzS3k?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene (ASX:IMU) Shares Drop 17.39% Despite Azer-cel CAR-T Therapy Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNbi1LY0QwNVdDa0pTeTVzbVdhbTNybDFUYTExUjZ3MEl6bzVjX25lVXlmcEE2dEZaV284X1Z2V2Y2dk9nbVFjdEFCNnFhTFYzeW4wbzRDVDRtaS1XdHo3SHg0ZHN4NTh6amVIc3EwQVdqTnVXcUxqWlRrTG9COHlDajl0VUNNWnd3aFJta0QzdW5hLUZIQkRJemNzd24zLTdqU1JTd200bEt6REE?oc=5", "source_name": "Kalkine", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMHlBODU4V2RzcnUybkFoWHo0RlViWG5vYmQwYlNOZ1gwUXh6bDl0OHJuWFFFSnhYTkRsSDBJLTdPSHpUVnVnTFljZjZPV3ZaNnFzX3EwVHBlUUtXU1R6c0ZuZXRoZlpkOHVsRlRFNFF5X1otRjdhb1dKSDlZcmdCRDMyOU9XT3BrSXZSQjROZFFTZzdGSWFKT0w0WVRJRXJKRWVpX0NQSUhoVUlKLTdSeUhXRmZKNHV6?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2025-12-08T08:00:00+00:00", "published_display": "08 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imugene's CAR-T therapy hits 82% response rate", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOT01ZWVVpbEZTVHk5dnBvVW8yZW80b1RfTW80TUZzTXZLZ2RkbEtQM0tVY0trOU5QWkpmaF9Fako5VEx4X042SXI3eEhjRjBpc1pQZGdUenVGcFM5dG1XazZ2cWpHd01XWVR3M1ZEajc4SVFJMUtiVU53cVd3RGRheThUN1BnbEs5bktRd3Z4UGd3Y1kwRDMwNHVTVE1XTG9nX0F3aUczVXFHZnFOV3h3TkRGdFRGRFNncUpB?oc=5", "source_name": "Proactive financial news", "published_at": "2025-12-01T08:00:00+00:00", "published_display": "01 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Imugene Ltd (ASX:IMU)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE91UXhRS0RlZUM4ODNYWW1WVWFYYVprNU5pLTA2b1FLZEkwWDRTY0hZWjdmWDFNNGtUQ0lBNGFzX2x3cG1SOWRQUXp2ZVJlRUMt?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T13:06:08+00:00", "published_display": "30 Oct 2025 13:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s what biotech Imugene needs to do before it can become a multibagger again", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxORHcwNWExQmYxQ2cwREhHb2ptaUUzOC05WTdSTWlwbVE4Z0FlQzlMc1Vmc1FBbUhBWm5NNmFLUldXbG5LNXRnaVpIYUhBczlhQ3Z4d24yRDJPV2NUY255SWxkQzNKczNYWXEzM3A3UHpVV2ZnNXhGaVM5R3NLaGthZTVQNy1sdmctNzgxT0VFSUVGdTZnWGxiWlltV1ZlR3daSzAzR25vZFhHaUJ2b3dPN3B3?oc=5", "source_name": "Stockhead", "published_at": "2022-08-25T07:00:00+00:00", "published_display": "25 Aug 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 82, "total_relevant": 25, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 22, "score": 52, "total": 25, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 94, "events": [{"event": "general", "label": "Market update", "weight": 13.2, "count": 24}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.1, "latest_week": "2026-07-10", "one_week_move": -22.2, "four_week_move": 15.4, "twelve_week_move": -30.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.883122, "market_dynamics_buy_signal": false, "relative_strength": -57.1907, "fair_value_gap": -92.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 28.3232, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-22.2% over one week, +15.4% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 65, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 13}, {"label": "Proactive financial news", "count": 4}, {"label": "grafa.com", "count": 2}, {"label": "The Globe and Mail", "count": 1}, {"label": "Kalkine Media", "count": 1}, {"label": "BiotechDispatch", "count": 1}, {"label": "The Motley Fool Australia", "count": 1}, {"label": "smallcaps.com.au", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 25}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 24}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "94/100 classification confidence."}, {"label": "Company focus", "value": "25", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-22.2% over one week, +15.4% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Imugene Limited Reports Lapse of 5,845 Restricted Stock Units Following Unmet Conditions"}], "updated_at": "2026-07-17T08:44:54.825241+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}